American Journal of Ophthalmology
Volume 148, Issue 5 , Pages 670-684 , November 2009

Three-Year Follow-up of the Tube Versus Trabeculectomy Study

  • Steven J. Gedde

      Affiliations

    • Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida
    • Corresponding Author InformationInquiries to Steven J. Gedde, Bascom Palmer Eye Institute, 900 N.W. 17th Street, Miami, FL 33136
    • ,
  • Joyce C. Schiffman

      Affiliations

    • Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida
    • ,
  • William J. Feuer

      Affiliations

    • Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida
    • ,
  • Leon W. Herndon

      Affiliations

    • Department of Ophthalmology, Duke University, Durham, North Carolina
    • ,
  • James D. Brandt

      Affiliations

    • Department of Ophthalmology, University of California, Davis, Sacramento, California
    • ,
  • Donald L. Budenz

      Affiliations

    • Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida
    • ,
  • Tube Versus Trabeculectomy Study Group

,Accepted 17 June 2009.

References 

  1. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology. 2007;114:2265–2270
  2. Chen PP, Yamamoto T, Sawada A, Parrish RK, Kitazawa Y. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. J Glaucoma. 1997;6:192–196
  3. Joshi AB, Parrish RK, Feuer WF. 2002 Survey of the American Glaucoma Society (Practice preferences for glaucoma surgery and antifibrotic use). J Glaucoma. 2005;14:172–174
  4. Gedde SJ, Schiffman JC, Feuer WJ, et al. The Tube Versus Trabeculectomy Study: Design and baseline characteristics of study patients. Am J Ophthalmol. 2005;140:275–287
  5. Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube Versus Trabeculectomy Study after one year of follow-up. Am J Ophthalmol. 2007;143:9–22
  6. Gedde SJ, Herndon LW, Brandt JD, et al. Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol. 2007;143:23–31
  7. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol. 1996;121:349–366
  8. Minckler DS, Francis BA, Hodapp EA, et al. Aqueous shunts in glaucoma: A report by the American Academy of Ophthalmology. Ophthalmology. 2008;115:1089–1098
  9. Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs. trabeculectomy in the surgical treatment of glaucoma: A randomized clinical trial. Am J Ophthalmol. 2000;130:267–273
  10. Wilson MR, Mendis U, Paliwal A, Haynatzka V. Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Am J Ophthalmol. 2003;136:464–470
  11. Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? (One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudphakia). Ophthalmology. 1992;99:1512–1519
  12. Shah AA, WuDunn D, Cantor LB. Shunt revision versus additional tube shunt implantation after failed tube shunt surgery in refractory glaucoma. Am J Ophthalmol. 2000;129:455–460
  13. Godfrey DG, Krishna R, Greenfield DS, et al. Implantation of second glaucoma drainage devices after failure of primary devices. Ophthalmic Surg Lasers. 2002;33:37–43
  14. The Fluorouracil Filtering Surgery Study Group. Fluorouracil Filtering Surgery Study one-year follow-up. Am J Ophthalmol. 1989;108:625–635
  15. The Fluorouracil Filtering Surgery Study Group. Fluorouracil Filtering Surgery Study three-year follow-up. Am J Ophthalmol. 1993;115:82–92
  16. Minckler DS, Heuer DK, Hasty B, Baerveldt G, Cutting RC, Barlow WE. Clinical experience with the single-plate Molteno implant in complicated glaucomas. Ophthalmology. 1988;95:1181–1188
  17. Freedman J, Rubin B. Molteno implants as a treatment for refractory glaucoma in black patients. Arch Ophthalmol. 1991;109:1417–1420
  18. Lloyd MA, Sedlak T, Heuer DK, et al. Clinical experience with the single plate Molteno implant in complicated glaucomas (Update of a pilot study). Ophthalmology. 1992;99:679–687
  19. Hodkin MJ, Goldblatt WS, Burgoyne CF, Ball SF, Insler MS. Early clinical experience with the Baerveldt implant in complicated glaucomas. Am J Ophthalmol. 1995;120:32–40
  20. Mills RP, Reynolds A, Emond MJ, Barlow WE, Leen MM. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology. 1996;103:299–305
  21. Huang MC, Netland PA, Coleman AL, Siegner SW, Moster MR, Hill RA. Intermediate-term clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1999;127:27–33
  22. Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success for Molteno tube implants. Br J Ophthalmol. 2001;85:689–695
  23. Roy S, Ravinet E, Mermoud A. Baerveldt implant in refractory glaucoma: Long-term results and factors influencing outcomes. Int Ophthalmol. 2001;24:93–100
  24. Heuer DK, Parrish RK, Gressel MG, Hodapp E, Palmberg PF, Anderson DR. 5-fluorouracil and glaucoma filtering surgery: II (A pilot study). Ophthalmology. 1984;91:384–394
  25. Heuer DK, Parrish RK, Gressel MG, et al. 5-fluorouracil and glaucoma filtering surgery: III (Intermediate follow-up of a pilot study). Ophthalmology. 1986;93:1537–1546
  26. Weinreb RN. Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology. 1987;94:564–570
  27. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98:317–321
  28. Prata JA, Minckler DS, Baerveldt G, Lee PP, LaBree L, Heuer DK. Trabeculectomy in pseudophakic patients: postoperative 5-fluorouracil versus intraoperative mitomycin C antiproliferative therapy. Ophthalmic Surg. 1995;26:73–77
  29. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol. 1990;6:175–182
  30. Singh J, O'Brien C, Chawla HB. Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye. 1995;9:460–466
  31. Andreanos D, Georgopoulos GT, Vergados J, Papaconstantinou D, Liokis N, Theodossiadis P. Clinical evaluation of the effect of mitomycin-C in re-operation for primary open-angle glaucoma. Eur J Ophthalmol. 1997;7:49–54
  32. You YA, Gu YS, Fang CT, Ma XQ. Long-term effects of simultaneous and subscleral mitomycin C application in repeat trabeculectomy. J Glaucoma. 2002;11:110–118
  33. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11 (Risk factors for failure of trabeculectomy and argon laser trabeculoplasty). Am J Ophthalmol. 2002;134:481–498
  34. Krishna R, Godfrey DG, Budenz DL, et al. Intermediate-term outcomes of 350-mm2 Baerveldt glaucoma implants. Ophthalmology. 2001;108:621–626
  35. Tsai JC, Johnson CC, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: A single-surgeon comparison of outcome. Ophthalmology. 2003;110:1814–1821
  36. Wang JC, See JL, Chew PT. Experience with the use of Baerveldt and Ahmed glaucoma drainage implants in an Asian population. Ophthalmology. 2004;111:1383–1388
  37. Syed HM, Law SK, Nam SH, Li G, Caprioli J, Coleman A. Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: A case-controlled comparison. J Glaucoma. 2004;13:38–45
  38. Smith MF, Doyle JW, Sherwood MB. Comparison of the Baerveldt glaucoma implant with the double-plate Molteno drainage implant. Arch Ophthalmol. 1995;113:444–447
  39. Ayyala RS, Zurakowski D, Monshizadeh R, et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers. 2002;33:94–101
  40. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953
  41. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7 (The relationship between control of intraocular pressure and visual field deterioration). Am J Ophthalmol. 2000;130:429–440
  42. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–1279
  43. Hylton C, Congdon N, Friedman D, et al. Cataract after glaucoma filtration surgery. Am J Ophthalmol. 2003;135:231–232
  44. Jampel HD, Musch DC, Gillespie BW, et al. Perioperative complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol. 2005;140:16–22
  45. Stein JD, Ruiz D, Belsky D, Lee PP, Sloan FA. Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among Medicare beneficiaries 1994 to 2005. Ophthalmology. 2008;115:1109–1116
  46. Javitt JC. Trab vs. tube, a 15-year retrospective: What have we learned in 20 years?. Ophthalmology. 2008;115:1107–1108
  47. Jones E, Clarke J, Khaw PT. Recent advances in trabeculectomy technique. Curr Opin Ophthalmol. 2005;16:107–113
  48. Wells AP, Cordeiro MF, Bunce C, Khaw PT. Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology. 2003;110:2192–2197

 See accompanying Editorial on page 634.

PII: S0002-9394(09)00453-X

doi: 10.1016/j.ajo.2009.06.018

American Journal of Ophthalmology
Volume 148, Issue 5 , Pages 670-684 , November 2009

Article Tools

* Image Usage & Resolution